Case Presentation & Discussion on Abdominal Vascular Emergency - - PowerPoint PPT Presentation

case presentation amp discussion on abdominal vascular
SMART_READER_LITE
LIVE PREVIEW

Case Presentation & Discussion on Abdominal Vascular Emergency - - PowerPoint PPT Presentation

Case Presentation & Discussion on Abdominal Vascular Emergency Oliver S. Leyson, MD Surgery Resident Department of Surgery Ospital Ng Maynila Medical Center General Data: O.L, 34 y/o, M Tondo, Manila Chief Complaint: Abdominal pain


slide-1
SLIDE 1

Case Presentation & Discussion on Abdominal Vascular Emergency

Oliver S. Leyson, MD Surgery Resident Department of Surgery Ospital Ng Maynila Medical Center

slide-2
SLIDE 2

General Data:

O.L, 34 y/o, M Tondo, Manila

slide-3
SLIDE 3

Chief Complaint:

Abdominal pain

slide-4
SLIDE 4

History of Present Illness:

8 days PTA epigastric pain crampy, non-radiating, persistent, not associated with food intake, no consult done Meds: buscopan 5mg tab afforded temporary relief no fever

slide-5
SLIDE 5

7 day PTA Persistence of pain prompted consult OMMC Dx: Non-ulcerative dyspepsia with no alarm signs Meds: AlMgOH syrup afforded some relief HAMA

slide-6
SLIDE 6

1 day PTA Persistence of pain prompted consult OMMC Dx: Non-ulcerative dyspepsia Meds: AlMgOH syrup HNBB amp TIM afforded some relief discharged with advised

slide-7
SLIDE 7

Few hours PTA Persistence of pain prompted consult private hospital Dx: Acute abdomen prob sec to ruptured appendicitis advised operation Patient opted to transfer to hospital of choice thus consult, hence Admission

slide-8
SLIDE 8

Past Medical History: no previous hospitalization (+) history of drug abuse: methampethamine HCL 1 month prior to admission Family History: Denies any heredo-familial disease Personal Social History: Smoker 12 pack years Occasional alcoholic beverage drinker

slide-9
SLIDE 9

Physical Examination:

Conscious, coherent, ambulatory, NICRD

  • BP:140/80 CR: 102 RR:21 T:37ºC
  • Pink palpebral conjunctiva, anicteric sclerae
  • Supple neck, (-) cervical LAD
  • Symmetrical chest expansion, clear breath

sounds

  • Adynamic precordium, tachycardic, regular

rhythm, PMI at 5th ICS LMCL, no murmur.

slide-10
SLIDE 10

Abdomen:

Flat, hypoactive bowel sounds, soft, with severe direct and rebound tenderness on all quadrants RLQ > LLQ No guarding

slide-11
SLIDE 11

Physical Examination

  • Rectal exam: no skin tags, no fissure good

sphincteric tone, with brown stool on examining finger, with parectal tenderness

  • Grossly normal extremities, no cyanosis, no

pallor

slide-12
SLIDE 12

Salient Features:

  • 34 y/o, male
  • 8 days history of abdominal pain
  • epigastric pain to generalized
  • Crampy, persistent, not relieved with food

intake

  • Vomiting, previously ingested food
  • No guarding
  • Severe direct and rebound tenderness
  • RLQ tenderness > LLQ
slide-13
SLIDE 13

Abdominal Pain

Surgical Non-surgical Traumatic NSRLQ pain UTI Pattern Recognition Non-traumatic

Acute Appendicitis Acute diverticulitis

34-year-old, male abdominal pain epigastric area Severe on the RLQ> LLQ

Vascular Occlusion

slide-14
SLIDE 14

Abdominal Pain

Surgical Non-surgical Traumatic NSRLQ pain UTI Prevalence Non-traumatic

Acute Appendicitis

Acute diverticulitis 34-year-old, male abdominal pain epigastric area Severe on the RLQ> LLQ

slide-15
SLIDE 15

Pre-Clinical Diagnosis:

Surgical 30% Acute Abdomen secondary to Acute diverticulitis Surgical 70% Acute Abdomen secondary to Ruptured Appendicitis Treatment Certainty Diagnosis

slide-16
SLIDE 16

Do I need a para-clinical diagnostic procedure? No, I do not need any para- clinical diagnostic procedure

Reasons: 1) My treatment option for my primary and secondary diagnosis are the same. 2) Presence of persistent abdominal pain

slide-17
SLIDE 17

Goal of treatment

  • Resolved the peritonitis
  • Remove the source of infection

(appendix)

  • Treat the infection
slide-18
SLIDE 18

Pre-op preparation:

  • Informed consent secured
  • Psychosocial support provided
  • Optimized patient’s physical health
  • Patient screened for any health

condition

  • Operative materials secured
slide-19
SLIDE 19

Pre-op preparation:

  • Large bore gauge 18 hypodermic needle

inserted for venoclysis

  • Foley catheter and naso-gastric tube

inserted.

  • Antibiotics were started

– Metronidazole 500mg TIV every 8 hrs – Choramphenicol 500mg TIV q 8 hrs

slide-20
SLIDE 20

Pre-op preparation:

  • Scheduled for exploratory laparotomy
  • Adequate hydration
slide-21
SLIDE 21
  • Patient placed under GA with R arm

extended

  • Asepsis and anti sepsis done
  • Sterile drapes placed
  • Midline incision was done
  • Intra-operative findings were noted

OPERATIVE TECHNIQUE

slide-22
SLIDE 22

Intra-Operative Findings

slide-23
SLIDE 23

Intra-Operative Findings

slide-24
SLIDE 24

Intra-operative findings:

Upon doing a midline incision, we noted a sero-purulent peritoneal fluid, there was a gangrenous segment of the small intestine about 90 cm from the ligament

  • f treitz, about 110 cm from the ileo-

cecal valve.

slide-25
SLIDE 25

Intra-operative findings:

With no pulse on the gangrenous segment while with poor pulse on the adjacent segment. Small bowel exhibited good capillary refill was noted on the unaffected segment. Liver, stomach, colon were grossly normal Appendix was normal.

slide-26
SLIDE 26

Abdominal Pain

Surgical Non-surgical Traumatic NSRLQ pain UTI Pattern Recognition Non-traumatic

Acute Appendicitis Acute diverticulitis

34-year-old, male abdominal pain epigastric area Severe on the RLQ> LLQ

Vascular Occlusion

slide-27
SLIDE 27

Abdominal Pain

Traumatic Non-traumatic

Pattern Recognition

Acute Appendicitis Acute diverticulitis

34-year-old, male abdominal pain epigastric area Severe on the RLQ> LLQ

Vascular Occlusion

slide-28
SLIDE 28

Abdominal Pain

Traumatic Non-traumatic

Pattern Recognition

34-year-old, male abdominal pain epigastric area Severe on the RLQ> LLQ Black tarry stool

Vascular Occlusion AMAE AMAT NOMI MVT

slide-29
SLIDE 29

Intra-operative Diagnosis:

Surgical 10% Acute Abdomen secondary to Gangrenous jejuno-ileal segment prob 20 Acute mesenteric arterial embolus Surgical 90% Acute Abdomen secondary to Gangrenous jejuno-ileal segment prob 20 Superior Mesenteric vein thrombosis Treatment Certainty Diagnosis

slide-30
SLIDE 30

Goal of treatment

  • 1. Maintain bowel continuity
  • 2. Resolution of bowel gangrene with

adequate and viable tissue margin

  • 3. No complication
slide-31
SLIDE 31

Intra-operative Management

  • Plan: resection-anastomosis of affected

bowel

slide-32
SLIDE 32
  • Intra-operative assesment was done
  • Referred to service consultant
  • Bowels were observed for pulsation

from the roots of the mesentery, the mesenteric proper and bowel segment.

OPERATIVE TECHNIQUE

slide-33
SLIDE 33

Open Method

Clamps are applied in such a Way that the tissue removed Placed crushing clamps and The bowels which remains for the anastomosis was held by Non-traumatic clamps Intestinal clamps ( Non-traumatic) Oschners clamp (crushing clamps)

slide-34
SLIDE 34
  • Following the removal of the

gangrenous segment, intestinal clamps are placed side by side

  • Posterior sero-serous sutures applied

using continues interlocking sutures with Chromic 3.0 round needle.

slide-35
SLIDE 35
  • Angle sutures applied using silk 2.0

(Maunsel mesenteric stich) and traction stich applied

  • Posterior layer of through-and-through

sutures using chromic 3.0 applied

slide-36
SLIDE 36
  • Anterior layer through-and-through with

continous interlocking sutures using Chromic 3.0 round needle.

  • Anterior serous sutures simple

interrupted using silk 3.0

slide-37
SLIDE 37
  • Anterior serous sutures simple

interrupted completes the anastomosis

  • The lumen was opened by finger

pressure on either side of the invaginated tissue (doughnut sign).

  • Rent in the mesentery sutured.
slide-38
SLIDE 38
  • Formal exploration done
  • Omentum placed over the remaining

segment

  • Correct instrument, needle and sponge

count

  • Layer by layer sutures applied on the

– Fascia closed using Vicryl 0 round needle continous suturing. – Reinforced External bolster applied pre- peritoneally using double Silk 0 strands on a carabao needle.

  • Povidone-iodine paint
  • DSD
slide-39
SLIDE 39

Post-operative Management

  • Maintained on NPO.
  • NGT and foley catheter monitored hourly.
  • Vital signs every hour.
  • Adequate analgesia given.
  • Venoclysis and IV antibiotics were

continued.

  • Input and output monitoring were recorded
slide-40
SLIDE 40

Post-operative Diagnosis:

Surgical 10% Acute Abdomen secondary to Gangrenous jejuno-ileal segment prob 20 Acute mesenteric arterial throbosis Surgical 90% Acute Abdomen secondary to Gangrenous jejuno-ileal segment prob 20 Superior Mesenteric arterial embolus Treatment Certainty Diagnosis

slide-41
SLIDE 41

Post-operative problems encountered

  • 1. Fever
  • 2. Dehydration
  • 3. LBM
  • 4. Phlebitis
slide-42
SLIDE 42

Problem 1) Fever

  • Developed on the 2nd post- operative day

low to moderate grade

  • Intervention: Assessed for hydration

– urine output was adequate 35 cc/ hr – central venous catheter was inserted and monitored – NGT and foley catheter was maintained – Paracetamol 300 mg amp was given thru IV – Continous tepid sponge bath rendered

slide-43
SLIDE 43

Problem 2) Dehydration

  • Developed on the 2nd post- operative day
  • Intervention: Assessed for hydration

– CVP line was inserted and monitored – Urine output was monitored – Fast drip of 200 cc of PLRS

slide-44
SLIDE 44

Problem 3) Loose bowel movement

  • Developed on the 5th post- operative day

watery black about 1/2 cup per bout 6 x

  • Intervention: Assessed for hydration

– Volume per volume replacement with present IVF – early institution of fluids per orem

slide-45
SLIDE 45

Problem 4) Phlebitis

  • Developed on the 5th post- operative day

tenderness on the IVF site

  • Intervention:

– re-insertion of IV fluid – warm compressed on affected site

slide-46
SLIDE 46

Expected complications

  • 1. Short bowel syndrome:
slide-47
SLIDE 47

Short Bowel Syndrome

  • average length adult human small

intestine 600 cm (260-800 cm).

  • Any disease, traumatic injury, vascular

accident, or other pathology that leaves less than 200 cm of viable small bowel places the patient at risk for developing short-bowel syndrome

Lennard-Jones JE: Review article: practical management

  • f the short bowel. Aliment Pharmacol Ther 1994 Dec;

8(6): 563-77[Medline]

slide-48
SLIDE 48

Short Bowel Syndrome

  • clinically defined by malabsorption, diarrhea,

fluid and electrolyte disturbances, and malnutrition.

  • The final common etiologic factor in all causes of

short-bowel syndrome is the functional or anatomic loss of extensive segments of small intestine so that absorptive capacity is severely compromised.

Lennard-Jones JE: Review article: practical management

  • f the short bowel. Aliment Pharmacol Ther 1994 Dec;

8(6): 563-77[Medline]

slide-49
SLIDE 49

Short Bowel Syndrome

  • Massive small intestinal resection

compromises digestive and absorptive processes.

  • Adequate digestion and absorption cannot

take place, and proper nutritional status cannot be maintained without supportive care.

Lennard-Jones JE: Review article: practical management

  • f the short bowel. Aliment Pharmacol Ther 1994 Dec;

8(6): 563-77[Medline]

slide-50
SLIDE 50

Short Bowel Syndrome

  • Examples

– mesenteric ischemia – Trauma – inflammatory bowel disease – Cancer – radiation enteritis – congenital short small bowel – midgut volvulus – multiple small bowel atresias – Gastroschisis – meconium peritonitis – necrotizing enterocolitis.

slide-51
SLIDE 51

Short Bowel Syndrome

  • Not all patients with loss of significant

amounts of small intestine develop the short-bowel syndrome.

Lennard-Jones JE: Review article: practical management

  • f the short bowel. Aliment Pharmacol Ther 1994 Dec;

8(6): 563-77[Medline]

slide-52
SLIDE 52

Short Bowel Syndrome

  • Important cofactors that help to

determine whether the syndrome will develop or not include

– premorbid length of small bowel – segment of intestine – age – remaining length of small bowel and colon – Presence or absence of the ileocecal valve.

Lennard-Jones JE: Review article: practical management

  • f the short bowel. Aliment Pharmacol Ther 1994 Dec;

8(6): 563-77[Medline]

slide-53
SLIDE 53

Short Bowel Syndrome

  • Significant weight loss
  • Fatigue, malaise, and lethargy.
  • Dehydration
  • Electrolyte imbalance
  • Protein-calorie malnutrition
  • Loss of critical vitamins and minerals.
slide-54
SLIDE 54

Prevention of Small Bowel Syndrome

  • Early institution of Total Parenteral Nutrition
slide-55
SLIDE 55

Total Parenteral Nutrition

  • an important therapy in the care of the

patient with short-bowel syndrome.

  • Provides adequate protein, calories, other

macronutrients, and micronutrients until the bowel has had time to adapt

  • Bowel compensation occurs after 3

months.

Carbonnel F, Cosnes J, Chevret S, et al: The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr.20(4): 275-80;1996 [Medline].

slide-56
SLIDE 56

Total Parenteral Nutrition

  • Wilmore and colleagues (1971) suggest

that supplementing enteral intake with parenteral nutrition early in the postoperative course results in better

  • verall bowel adaptation.
  • This is most likely because it facilitates

provision of adequate calorie and nitrogen sources.

Wilmore DW, Dudrick SJ, Daly JM, Vars HM: The role of nutrition in the adaptation of the small intestine after massive resection. Surg Gynecol Obstet.132(4): 673-80;1971[Medline].

slide-57
SLIDE 57

Total Parenteral Nutrition

–Calculate the Ideal body weight (IBW)

  • Male: 106 lbs for the first 5’ & 6 lbs per inch
  • Female: 100 lbs for the first 5’ & 5 lbs per

inch

– Our patient 5’4 male: 106 + 24 = 130 lbs ( divided by 2.2 lbs/kg) = 59 kgs

slide-58
SLIDE 58

–Calculate for protein need

  • 1 g/kg/day – non-stressed
  • 1.5g/kg/day – stressed
  • 2.0 g/kg/day – severe stressed

– our patient: 59 kg x 1.5 g/kg/day = 88.5 g

protein/day needed

  • 1 gram protein = 4 kcal energy
  • 85.5 g/day x 4 kcal energy = 354

kcal/day proteins

slide-59
SLIDE 59
  • Calculate Non-protein calories

–25 kcal/kg/day – non-stressed –30 kcal/kg/day – stressed –35 kcal/kg/day – severe stressed

  • Our patient: 59 kg x 30 kcal/kg/day = 1770

kcal/day

slide-60
SLIDE 60
  • Determine CHO : Lipid ratio

– 65% CHO – 35% lipids – 70% CHO – 30% lipids – 75% CHO – 25% lipids – 80% CHO – 20% lipids

  • Estimate the need based on patient

disease and co-morbidities

  • 1770 kcal/day needed from non-protein

calories

  • 70% CHO = 1239 kcal/day from CHO
  • 30% lipids = 531 kcal/day from lipids
slide-61
SLIDE 61
  • Calculate the grams needed and ml solution

– 1 gram CHO = 3.4 kcal energy – our patient: 1239 kcal/day from CHO – 1239 kcal/day / 3.4 kcal of energy = 364 g CHO

  • By using D50 solution (500 g CHO/Liter) you can

multiply the number of grams needed by 2 to determine how many ml needed.

– 364 g CHO / 0.5 = 729 ml of D 50 solution

slide-62
SLIDE 62
  • 1 gram lipids = 9 kcal energy/

– 531 kcal lipids needed/day = 59 g Lipids/day

  • If using a 20% solution, 1 cc = 2 kcal energy
  • If using a 10% solution, 1 cc = 1 kcal energy

– take the number of kcal needed and divide by 2 to determine the number of ml of a 20% lipid solution

  • 531 kcal/day needed = 531 / 2 = 266 cc of a 20%

lipid sol (11 cc/hr x 24 hrs)

slide-63
SLIDE 63
  • Calculate the Total Fluids Needed

– Usual estimate: 25 – 35 cc/kg/day

  • 59 kg male, 30 cc/kg/day fluid = 1770cc/fluid/day

– subtract lipid amount from total

  • 1770 cc – 266 cc = 1504 cc TPN + Fluid/day

– add free water to make up difference – divide the total volume by 24 hrs to determine the hourly rate

  • 1504 cc / 24 hrs = 62 cc TPN sol / hr
slide-64
SLIDE 64

Course in the wards

  • TPN was started on the 8th HD with

Nutripack 1900 kcal at 62 cc TPN/hr

  • IVF and IV meds were continued
  • Early enteral feeding were started and

tolerated

  • Rest of his stay was unremarkable
  • Patient was discharged on the 21st HD
slide-65
SLIDE 65

Follow-Up Care

  • Advised to come back at Out Patient

Department 1 week after discharged

  • Daily bathing including the wound
  • Daily wound care
  • Small stiches were removed after 1 week
  • Bolster sutures will to be removed after 1

month

slide-66
SLIDE 66

Follow-Up Care

  • Oral medications were continued at home

– Cloxacillin 500 mg cap every 6 hrs for 7 days – Mefenamic Acid 500 mg cap every 8 hrs for pain with meals

slide-67
SLIDE 67

Follow-up plan:

  • Patients require lifetime follow-up for

subsequent complications

  • Patients should be weighed regularly to

assure that they are not losing weight on the nutritional regimen they are receiving.

  • Several smaller feedings per day are

usually advisable

slide-68
SLIDE 68

Prevention and Health Promotion

  • Changes diet
  • More physically active
  • Lose weight
  • Taking medications
  • Quit smoking
  • Stop using drugs
  • Educate patients who survive to discharge

about short-bowel syndrome

slide-69
SLIDE 69

Outcome:

  • Resolution of the bowel gangrene
  • Live patient
  • Discharged
  • Happy and contented with the outcome
  • No complications
  • Satisfied patient
  • No medico-legal suit
slide-70
SLIDE 70

Final Histopathologic Diagnosis

  • to be discussed by Dr Jane Nicoza
slide-71
SLIDE 71

Sharing of Information:

slide-72
SLIDE 72

Acute Mesenteric Ischemia

  • is a syndrome in which inadequate blood

flow through the mesenteric circulation causes ischemia and eventual gangrene

  • f the bowel wall.
  • The syndrome can be classified generally

as arterial or venous disease.

slide-73
SLIDE 73

Arterial disease can be subdivided

–Nonocclusive mesenteric ischemia (NOMI) –Occlusive mesenteric arterial ischemia (OMAI)

  • Acute mesenteric arterial embolus (AMAE)
  • Acute mesenteric arterial thrombosis (AMAT)
slide-74
SLIDE 74

4 different primary clinical entities:

  • Acute mesenteric arterial embolus (AMAE)
  • Acute mesenteric arterial thrombosis (AMAT)
  • Non-occlusive Mesenteric Ischemia (NOMI)
  • Mesenteric venous thrombosis (MVT)
slide-75
SLIDE 75

Anatomy

  • Celiac artery (CA) supplies the foregut,

hepatobiliary system, and spleen

  • Superior mesenteric artery (SMA) supplies

the midgut (ie, small intestine and proximal mid colon)

  • Inferior mesenteric artery (IMA) supplies the

hindgut (ie, distal colon and rectum), but multiple anatomic variants are observed.

  • Venous drainage is through the superior

mesenteric vein (SMV), which joins the plenic vein to become the portal vein.

slide-76
SLIDE 76

Acute Mesenteric Ischemia

  • arises primarily from problems in the SMA

circulation or its venous outflow.

  • Collateral circulation from the CA and IMA may

allow sufficient perfusion if flow in the SMA is reduced because of occlusion, low-flow state (NOMI), or venous occlusion.

  • The inferior mesenteric artery seldom is the site
  • f lodgment of an embolus. Only small emboli

can enter this vessel because of its smaller lumen.

slide-77
SLIDE 77

Pathophysiology:

  • Insufficient blood perfusion to the small

bowel and colon may result from arterial

  • cclusion by embolus or thrombosis

(AMAE or AMAT), thrombosis of the venous system (MVT), or nonocclusive processes such as vasospasm or low cardiac output (NOMI).

slide-78
SLIDE 78
  • Arterial embolism = 50%
  • Arterial thrombosis = 25%,
  • NOMI = 15%
  • MVT =10%.
  • Hemorrhagic infarction is the common

pathologic pathway whether the occlusion is arterial or venous

slide-79
SLIDE 79
  • Damage to the affected bowel portion may

range from reversible ischemia to transmural infarction with necrosis and perforation.

  • The injury is complicated by reactive

vasospasm in the SMA region after the initial occlusion.

  • Arterial insufficiency causes tissue

hypoxia, leading to initial bowel wall spasm.

slide-80
SLIDE 80
  • This leads to gut emptying by vomiting or

diarrhea.

  • Mucosal sloughing may cause bleeding

into the gastrointestinal tract. At this stage, little abdominal tenderness is usually present, producing the classic intense visceral pain disproportionate to physical examination findings.

slide-81
SLIDE 81
  • The mucosal barrier becomes disrupted as

the ischemia persists, and bacteria, toxins, and vasoactive substances are released into the systemic circulation.

  • This can cause death from septic shock,

cardiac failure, or multisystem organ failure before bowel necrosis actually

  • ccurs.
slide-82
SLIDE 82
  • As hypoxic damage worsens, the bowel

wall becomes edematous and cyanotic.

  • Fluid is released into the peritoneal cavity,

explaining the sero-sanguinous fluid

  • Bowel necrosis can occur in 8-12 hours

from the onset of symptoms.

  • Transmural necrosis leads to peritoneal

signs and heralds a much worse prognosis.

slide-83
SLIDE 83

Superior Mesenteric Vein Thrombosis

  • 2 types

– Primary – no predisposing factor – Secondary - 80% result of predisposing factor

slide-84
SLIDE 84

Predisposing factor

  • Intra-abdominal infection
  • phlebitis or pylephlebitis (portal pyemia)
  • diverticulitis,
  • Appendicitis
  • infected carcinoma of the bowel
  • hypercoagulable states (polycythemia vera)
slide-85
SLIDE 85
  • oral contraceptives
  • protein C or S deficiency
  • mesenteric venous stasis from portal

hypertension or mass effect of abdominal tumors

  • direct trauma to the mesenteric veins

from a surgical procedure.

Predisposing factor

slide-86
SLIDE 86

Predisposing factor

  • after ligation of the portal vein or the

superior mesenteric vein as part of "damage-control surgery" for severe penetrating abdominal injuries.

  • Other associated causes include

pancreatitis, sickle cell disease, and hypercoagulability caused by malignancy.

slide-87
SLIDE 87
  • 30-40-years-old
  • Symptoms may be present longer than in

the typical cases of AMI, (>30 days)

  • Infarction from MVT is rarely observed

with isolated SMV thrombosis, unless collateral flow in the peripheral arcades or vasa recta is compromised as well.

  • Fluid sequestration and bowel wall edema

are more pronounced than in arterial

  • cclusion.
slide-88
SLIDE 88

Frequency:

  • 0.1% of all hospital admissions
slide-89
SLIDE 89

Mortality/Morbidity

  • MVT has a 30-day mortality rate of 13-

15%.

slide-90
SLIDE 90

Race:

  • No racial predilections are known for AMI
  • However, people of races with a higher

rate of conditions leading to atherosclerosis, such as black people, might be at higher risk.

slide-91
SLIDE 91

Sex

  • No overall sex preference exists for AMI.
  • Men might be at higher risk for occlusive

arterial disease because they have a higher incidence of atherosclerosis.

  • Conversely, women who are on oral

contraceptives or are pregnant are at higher risk of MVT.

slide-92
SLIDE 92

Age:

  • AMI is frequently considered a disease of

people older than 50 years.

  • Younger people with atrial fibrillation or

risk factors for MVT, such as oral contraceptive use or hypercoagulable states (eg, those caused by protein C or S deficiency), may present with AMI.

slide-93
SLIDE 93

History:

  • The most important finding is pain

disproportionate to physical examination findings.

  • Typically, pain is moderate to severe,

diffuse, nonlocalized, constant, and sometimes colicky.

slide-94
SLIDE 94
  • Nausea and vomiting are found in 75%
  • Anorexia, diarrhea, obstipation
  • Abdominal distension and GI bleeding are

25% of patients.

  • Pain may be unresponsive to narcotics.
  • rectal bleeding and signs of sepsis (eg,

tachycardia, tachypnea, hypotension, fever, altered mental status) develop.

slide-95
SLIDE 95

Lab Studies:

  • CBC count: Leukocytosis and/or leftward

shift are (50%)

  • Plain abdominal films: ileus, small bowel
  • bstruction, edematous/thickened bowel

walls, and paucity of gas in the intestines. More specific signs, such as pneumatosis intestinalis, ie, submucosal gas thumb printing of bowel wall; and portal vein gas, are late findings.

slide-96
SLIDE 96

Angiography

  • standard for diagnosis
  • To promptly diagnose patients with true AMI, a

low threshold for obtaining early angiography should be adopted for patients at risk.

  • Sensitivity is reported to be 88%
  • thrombus in the SMV
  • reflux of contrast into the aorta
  • prolonged arterial phase with accumulation of

contrast and thickened bowel walls

  • extravasation of contrast into bowel lumen, and

filling defect in the portal vein

  • complete lack of venous phase.
slide-97
SLIDE 97

Surgical Care:

  • exploratory laparotomy and resection of

infarcted bowel is indicated.

slide-98
SLIDE 98

Further Outpatient Care:

  • Heparin - For patients with MVT or after

revascularization

slide-99
SLIDE 99

Salamat Po……..

slide-100
SLIDE 100

References:

1. Lennard-Jones JE: Review article: practical management of the short bowel. Aliment Pharmacol Ther; 8(6): 563-77,1994. 2. Wilmore DW, Dudrick SJ, Daly JM, Vars HM: The role of nutrition in the adaptation of the small intestine after massive resection. Surg Gynecol Obstet.132(4): 673-80;1971.

3. Carbonnel F, Cosnes J, Chevret S, et al: The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr.20(4): 275-80;1996.

4.

Howard L, Heaphey L, Fleming CR, et al: Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J Parenter Enteral.15(4): 384-93;1991.

slide-101
SLIDE 101

References:

1. Boley SJ, Brandt LJ, Sammartano RJ: History of mesenteric

  • ischemia. The evolution of a diagnosis and management. Surg

Clin North Am.77(2): 275-88;1997. 2. Klempnauer J, Grothues F, Bektas H: Long-term results after surgery for acute mesenteric ischemia. Surgery. 121(3): 239-43 1997.

3. Hassan HA, Raufman JP: Mesenteric venous thrombosis. South Med J. 92(6): 558-62;1999. 4. McKinsey JF, Gewertz BL: Acute mesenteric ischemia. Surg Clin North

  • Am. 77(2): 307-18;1997.
slide-102
SLIDE 102

Questions

1. Among the four distinct pathophysiologic mechanism of Acute Mesenteric ischemia, the most common caused is? a. Arterial thrombi b. Arterial emboli c. Venous thrombosis d. NOMI

slide-103
SLIDE 103

Questions

1. Among the four distinct pathophysiologic mechanism of Acute Mesenteric ischemia, the most common caused is? a. Arterial thrombi b. Arterial emboli c. Venous thrombosis d. NOMI

slide-104
SLIDE 104
  • 2. Mesenteric Venous Thrombosis accounts for
  • nly 5-10% of acute mesenteric ischemia and

in 95%of cases this vessel is involved? a. Splenic vein b. Portal vein c. Superior mesenteric vein d. Inferior mesenteric vein

slide-105
SLIDE 105
  • 2. Mesenteric Venous Thrombosis accounts for
  • nly 5-15% of acute mesenteric ischemia and

in 95%of cases this vessel is involved? a. Splenic vein b. Portal vein c. Superior mesenteric vein d. Inferior mesenteric vein

slide-106
SLIDE 106
  • 3. Regardless on the pathophysiologic mechanism of acute

mesenteric ischemia. What is the hallmark findings on physical examination of the abdomen? a. Abdominal distention b. Abdominal pain out of proportion to the degree of tenderness c. Muscle guarding d. Rebound tenderness

slide-107
SLIDE 107
  • 3. Regardless on the pathophysiologic mechanism of acute

mesenteric ischemia. What is the hallmark findings on physical examination of the abdomen? a. Abdominal distention b. Abdominal pain out of proportion to the degree of tenderness c. Muscle guarding d. Rebound tenderness

slide-108
SLIDE 108
  • 4. The two distinct clinical syndromes of acute

mesenteric ischemia are ?

a. Acute mesenteric ischemia b. Mesenteric Venous thrombosis c. Chronic mesenteric ischemia d. Non-occlusive Mesenteric ischemia

slide-109
SLIDE 109
  • 4. The two distinct clinical syndromes of acute

mesenteric ischemia are ?

a. Acute mesenteric ischemia b. Mesenteric Venous thrombosis c. Chronic mesenteric ischemia d. Non-occlusive Mesenteric ischemia

slide-110
SLIDE 110
  • 5. What are the important cofactors that will help to

determine whether the short bowel syndrome would develop or not includes?

  • a. segment of intestine
  • b. age
  • c. remaining length of small bowel and colon
  • d. Presence or absence of the ileocecal valve.
slide-111
SLIDE 111
  • 5. What are the important cofactors that will help to

determine whether the Short bowel syndrome would develop or not includes?

  • a. segment of intestine
  • b. age
  • c. remaining length of small bowel and colon
  • d. Presence or absence of the ileocecal valve.
slide-112
SLIDE 112

√√ √√

Anastomotic leak xxxx

Closed √√ √√

Anastomotic leak xxx

Open Availability Cost Risk Benefit